NEW YORK (GenomeWeb) – Sciex said today that its AB Sciex Triple Quad 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration for use as a medical device.

With the approval, the system, which consists of the LC-MS/MS instrumentation along with Sciex's Analyst MD, Cliquid MD, and MultiQuant MD software, can be used in China for in vitro diagnostic testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.